SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
SLE
is a chronic inflammatory immune disorder affecting the skin and other body
organs. Antibodies to DNA and RNA cause an autoimmune inflammatory response,
resulting in swelling and pain. It is most common in young women, and has a
strong genetic factor. The etiology is not known.
PROGNOSIS
Prognosis
is good but is consistent with many remissions and exacerbations. Most patients
do quite well on a course of medications, but some progress rapidly with severe
organ involvement and subsequently, death. Certain medications may produce
lupus-like symptoms in patients. Are view of medications is indicated before a
diagnosis is made.
SIGNS
AND SYMPTOMS
•
Butterfly rash on face due to deposition of immunoglobulin and complement in
the skin.
•
Fatigue may be due to anemia
•
Anemia due to inflammation
•
Fever, malaise
•
Joint pain
INTERPRETING
TEST RESULTS
•
Positive antinuclear antibody test—antibodies are present in the blood.
•
Positive rheumatoid factor.
TREATMENT
Treatment
of SLE is supportive. The drugs used should match the stage the patient is in
at the time. Treatment of systemic signs is dependent on the organ system
involved.
•
Administer NSAIDs to decrease the inflammation and give analgesic effects:
•
Ibuprofen
•
Flurbiprofen
•
Indomethacin
•
Sulindac
•
Naproxen
•
Diclofenac
•
Antimalarials
•
Administer immunosuppressants in patients who are unresponsive to
corticosteroids:
•
Azathioprine
•
Cyclophosphamide
•
Administer analgesic:
•
NSAIDs
•
Aspirin
•
Acetaminophen
•
Tramadol
NURSING
DIAGNOSES
•
Impaired mobility
•
Disturbed body image
•
Ineffective protection
•
Chronic pain
NURSING
INTERVENTION
•
Avoid sunlight.
•
Cover butterfly rash with cosmetics.
•
Reduce stress.
•
Monitor for infections.
Comments
Post a Comment